Latest Breaking News On - Meeting may - Page 1 : comparemela.com

Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab

Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesHana starobovaUz leuven gashuisbergEric van cutsemUniversity of queenslandNews networkNasdaq stockholmMeeting mayVon hoff

Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting Neuropathy

LUND, SWEDEN / ACCESSWIRE / June 1, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today gave a presentation at the ASCO conference showing clinical data on nadunolimab

United statesUz leuven gashuisbergEric van cutsemHana starobovaUniversity of queenslandNasdaq stockholmMeeting mayVon hoffIhr portfolio

Iovance Biotherapeutics : IOV COM 202 Cohort 1A ASCO 2024 Oral Presentation

Iovance Biotherapeutics : IOV COM 202 Cohort 1A ASCO 2024 Oral Presentation
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomComunidad autonoma de catalunaUnited statesSan carlosJuan martinGuang chenSajeve thomasDurani reynalsSpeville uribeUniversitario marquAndrewjs furnessDonald lawrencePatrick terheydenBrian gastmanSylvia lee

OneOncology Highlights Research Contributions at 2024 ASCO Annual Meeting

OneOncology Highlights Research Contributions at 2024 ASCO Annual Meeting
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesIanw flinnSatish shahTodd bauerKent shihYuanbin chenResearch instituteHematology centersMeeting mayPennsylvania cancer specialistsChief scientific officer

Cantargia Presents New Positive Clinical Data on Nadunolimab Counteracting Chemotherapy Induced Neuropathy

Cantargia disclosed new clinical data indicating that nadunolimab counteract the serious problem of chemotherapy induced neuropathy, in addition to previously reported promising antitumor effects. The.

Meeting may